BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10408246)

  • 1. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
    Le Guen S; Catheline G; Besson JM
    Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine tolerance increases [3H]MK-801 binding affinity and constitutive neuronal nitric oxide synthase expression in rat spinal cord.
    Wong CS; Hsu MM; Chou YY; Tao PL; Tung CS
    Br J Anaesth; 2000 Oct; 85(4):587-91. PubMed ID: 11064618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
    Catheline G; Le Guen S; Besson JM
    Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
    Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
    Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tolerance to the antinociceptive effect of systemic morphine at the lumbar spinal cord level: a c-Fos study in the rat.
    Le Guen S; Catheline G; Besson JM
    Brain Res; 1998 Nov; 813(1):128-38. PubMed ID: 9824685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?
    Honoré P; Chapman V; Buritova J; Besson JM
    Brain Res; 1995 Dec; 705(1-2):91-6. PubMed ID: 8821738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
    Chapman V; Buritova J; Honoré P; Besson JM
    J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine and NMDA receptor antagonism reduce c-fos expression in spinal trigeminal nucleus produced by acute injury to the TMJ region.
    Bereiter DA; Bereiter DF
    Pain; 2000 Mar; 85(1-2):65-77. PubMed ID: 10692604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression.
    Honoré P; Chapman V; Buritova J; Besson JM
    Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats.
    Honoré P; Catheline G; Le Guen S; Besson JM
    Pain; 1997 May; 71(1):99-108. PubMed ID: 9200179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor antagonists attenuate noxious and nonnoxious colorectal distention-induced Fos expression in the spinal cord and the visceromotor reflex.
    Traub RJ; Zhai Q; Ji Y; Kovalenko M
    Neuroscience; 2002; 113(1):205-11. PubMed ID: 12123698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
    Honoré P; Buritova J; Besson JM
    Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contributions of NMDA and non-NMDA receptors to spinal Fos expression evoked by superficial tissue and muscle inflammation in the rat.
    Hu JY; Zhao ZQ
    Neuroscience; 2001; 106(4):823-31. PubMed ID: 11682167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptors are involved in upstream of the spinal JNK activation in morphine antinociceptive tolerance.
    Guo RX; Zhang M; Liu W; Zhao CM; Cui Y; Wang CH; Feng JQ; Chen PX
    Neurosci Lett; 2009 Dec; 467(2):95-9. PubMed ID: 19818835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats.
    Shen N; Mo LQ; Hu F; Chen PX; Guo RX; Feng JQ
    CNS Neurosci Ther; 2014 Aug; 20(8):728-36. PubMed ID: 24629168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
    Chapman V; Honoré P; Buritova J; Besson JM
    Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274614.
    Zhu H; Brodsky M; Gorman AL; Inturrisi CE
    Brain Res Mol Brain Res; 2003 Jun; 114(2):154-62. PubMed ID: 12829326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.